ORIGINAL ARTICLE
Year : 2015  |  Volume : 8  |  Issue : 4  |  Page : 560-566

The effect of esmolol infusion as an adjunct to total intravenous anesthesia on the total anesthetic and analgesic requirements in arthroscopic shoulder surgery


Anesthesia Department, Ain Shams University, Cairo, Egypt

Correspondence Address:
Sherif A Elokda
Anesthesia Department,, Ain Shams University, Abbasia, Cairo 11455
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1687-7934.172741

Rights and Permissions

Background Esmolol is the first intravenous, short-acting, titratable b-blocker for use in critical care and surgical settings. It influences core components of an anesthetic regimen, such as analgesia, hypnosis, and memory function. Aims To investigate whether perioperative esmolol infusion as an adjuvant to total intravenous anesthesia could affect the total anesthetic and analgesic requirements in adult patients undergoing arthroscopic shoulder surgery. Settings and design A randomized, double-blinded, prospective study. Materials and methods Eighty adult ASA I and II patients scheduled for elective arthroscopic rotator cuff repair were randomized into the esmolol group (n = 40) and the control group (n = 40). In the esmolol group, 1 mg/kg esmolol was given as a bolus over 30 s, followed by 15 mg/kg/min as an intravenous infusion, and in the control group, the same volume of normal saline was given during the same time period. The heart rate, the mean arterial blood pressure, the depth of anesthesia, the duration of anesthesia, the recovery time, total anesthetic requirements, the postoperative pain score (VAS), and the total postoperative analgesic requirements were monitored and calculated during the perioperative period. Results There was no significant difference between both groups regarding the demographic data using the unpaired t-test. There was a significant difference between both groups (P < 0.05) regarding different parameters, except the duration of anesthesia, using the unpaired t-test. Preoperative mean values of heart rate (beats/min) and the mean arterial blood pressure (mmHg) were comparable between the two groups (P > 0.05). However, after induction of anesthesia and thereafter, there was a significant reduction in heart rate and mean arterial blood pressure mean values in the esmolol group when compared with the control group (P < 0.05). A significant change in bispectral index was noticed within each group in comparison with the baseline using the paired t-test. However, there was no significant difference between both groups. Postoperative pain assessments by VAS (0-100 mm) showed significantly lower pain scores in the esmolol group compared with the control group by the paired t-test (P < 0.05). There was a highly significant reduction (P < 0.001) in the total cumulative doses of morphine consumption by PCA during the first 24 h in the esmolol group compared with the control group. Conclusion Perioperative esmolol infusion reduces the total anesthetic and analgesic requirements and postoperative pain. Hence, esmolol can be considered as safe and suitable adjuvant to total intravenous anesthesia.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed764    
    Printed10    
    Emailed1    
    PDF Downloaded137    
    Comments [Add]    
    Cited by others 1    

Recommend this journal